The ITM2B gene helps nerve cells manage certain proteins, especially in the brain. When it does not work properly, protein buildup can damage brain tissue over time. Pathogenic variants in this gene are linked to rare inherited conditions that may lead to gradual changes in memory, thinking, movement, vision, or hearing. Most people only hear about the ITM2B gene when a family is being evaluated for one of these uncommon forms of dementia.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do the work. Other genes mainly help direct when certain processes happen, where they occur, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in greater depth, you can find more in the LearnHub.
Overview
ITM2BGene function
What if the gene works
The ITM2B gene helps make BRI2, a protein active in brain cells. It helps control how certain proteins are processed and supports normal nerve cell function.
Risk
What if the gene does not work
Pathogenic variants in the ITM2B gene can cause rare inherited brain amyloid disease, often with progressive memory and thinking decline, balance problems, and vision loss. Milder or more severe variants may change which features appear and when symptoms begin.
Treatment
What does that mean for your treatment
At present, no ITM2B-specific treatment or drug selection approach is established in clinical guidelines; care is supportive and based on symptoms. The ITM2B gene is being studied in rare inherited dementia and amyloid research, but this has not yet changed routine treatment choices.
Conditions associated with ITM2B
Gene function
What if the gene works
In your body, the ITM2B gene supports routine protein handling, especially in nerve cells. Its protein sits in cell membranes and helps control how certain other proteins are moved and cut into smaller pieces. Much of the ITM2B gene function centers on how brain cells handle key proteins during everyday signaling.
The ITM2B gene helps control how certain membrane proteins are cut into smaller pieces. This is especially important for APP, a protein that nerve cells use during normal signaling.
The ITM2B gene makes a protein that sits in the cell membrane, where it can meet other proteins directly. This location helps it influence protein handling at the cell surface and inside the cell.
By guiding how APP is handled, the ITM2B gene supports steady communication between brain cells. This helps keep normal signaling activity more balanced in the nervous system.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental factors. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How variants influence the ITM2B gene's function often comes down to altered protein processing. Some pathogenic variants change the stop signal, so the cell makes an abnormally long protein that is cut into unusual peptide fragments, which can build up and disrupt nearby cells. Different variants can have milder or more disruptive effects on protein shape, stability, and cutting, and the more disruptive changes are often linked to earlier or more severe brain and eye findings.
How variants are linked to conditions
Conditions linked to variants in the ITM2B gene include rare inherited cerebral amyloid angiopathy (protein buildup in brain blood vessels), especially familial British dementia and familial Danish dementia. These conditions are caused by pathogenic variants in the ITM2B gene and can lead to gradual changes in memory, thinking, balance, vision, and sometimes stroke-like events. They are passed down in an autosomal dominant pattern, so a parent with the variant can pass it to a child.
A variant is not necessarily a diagnosis
Variants are a usual part of human biology and are common across the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ITM2B, risk is mainly shaped by whether a disease-causing change in the gene is present and runs in the family. There is not enough evidence to say that lifestyle factors meaningfully lower or raise the chance of developing an ITM2B-related condition. In families with a known ITM2B change, paying attention to early changes in memory, balance, vision, or headaches can help with earlier care.
Inheritance of ITM2B variants
In families looking into how ITM2B variants are inherited, the usual pattern is autosomal dominant. This means a person with a disease-causing variant in one copy of the ITM2B gene can pass it to a child, and each pregnancy carries a 50% chance of inheriting that variant. Sons and daughters are affected at similar rates, and either parent can pass the variant on.
What does my ITM2B result mean for my family?
For ITM2B, the main recognized conditions in families are passed down in a dominant pattern. This means close relatives, such as a parent, brother, sister, or child, may also carry the same gene change and could have their own chance of developing related symptoms, often later in adult life. Because this can run through generations, the result may matter for several family members, not only the person tested.
Genetic information
Genetic testing
How you find out about variants
ITM2B genetic testing looks for variants in the ITM2B gene using a blood sample, saliva, or a cheek swab. A lab reads the gene’s DNA code to check for a known family variant or other changes, which can help confirm whether a condition linked to the ITM2B gene is present in someone with suggestive symptoms.
When should I consider getting a genetic test?
Genetic testing for the ITM2B gene may be worth considering if several relatives have had early memory decline or dementia, especially along with balance, movement, hearing, or vision problems. Testing is usually considered as part of an evaluation for a rare inherited brain condition and guided by a neurologist or genetic counselor.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal varies by the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. For some conditions, especially those shaped by many genes, genetic information gives context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This is one reason the same medication may work well for one person, have little effect in another, or cause more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way medications work. It focuses on gene drug patterns to help explain why the same treatment may have different effects from one person to another. With many medicines, genes can influence either how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more tailored to the individual. More detail on this topic is available in the LearnHub.
Drugs influenced by the ITM2B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose, so questions about symptoms, side effects, or treatment are best discussed with your doctor or pharmacist.
History
The ITM2B gene entered medical genetics through studies of rare inherited dementias in families from the United Kingdom and Denmark. In the late 1990s, researchers linked unusual changes near this gene to familial British dementia and familial Danish dementia, helping explain why these conditions ran in certain families. Initially understood only through visible traits, later recognized as tied to a specific gene, these discoveries gave doctors a clearer way to classify two conditions that had puzzled clinicians. Building on this early work, scientists showed that the gene had first been called BRI2 in older reports before ITM2B became the standard name. These findings made ITM2B an important part of the history of inherited dementia research.